67.5 F
New York
Thursday, June 8, 2023



PharmStars Now Accepting Applications for Spring 2022 Accelerator Program; Startups with Digital Innovations in Neurological Disease Are Welcome to Apply

Related Articles

CBD Online Store Rebrands as Qinneba: Embracing the Past, Embracing the Future

Laguna Hills, CA, June 07, 2023 --(PR.com)-- CBD Online Store, a prominent provider of high-quality CBD products, is excited to announce its rebranding as Qinneba....
Boston, MA, January 04, 2022 –(PR.com)– PharmStars, the pharma-focused accelerator for digital health startups, is delighted to announce that it is now accepting applications for its spring 2022 cohort with the theme, “Digital Innovations in Neurological Disease.”

Neurological disease is an area with tremendous need for digital innovations to improve patient outcomes. PharmStars’ spring 2022 cohort will bring together startups with digital innovations spanning multiple neurological conditions (including but not limited to Alzheimer’s, Parkinson’s, ALS, pain, and depression). These digital health innovations may be diagnostics, therapeutics, or solutions from any part of the care continuum from disease tracking to patient monitoring. Digital health startups with products or prototypes who want to partner with pharma are invited to apply by February 4, 2022.

PharmStars focuses on bridging the “pharma-startup gap” by…

Read more…

Popular Articles